| Laser
Therapeutics, Inc. is an exciting U.S. based company
established by a group of dedicated medical professionals to
thoroughly research, document and implement the latest in low
powered, non-invasive laser technology. We are the only U.S.
company representing the following low level therapy lasers:
The Beurer Softlaser, the Maestro Low Level Laser by MediCom,
the Levelaser series of powered diode lasers, the FDA cleared Omega Laser
Systems LLLT Lasers and CTL Laser Systems.
Laser
Therapeutics is in the final stages of its FDA clinical trial
investigation of low level laser therapy (LLLT) on a number of
conditions and developing additional protocols as part of
pretrial investigations. A review of the literature shows that
Low level laser therapy has proven effective for many conditions
that have not responded well to other forms of treatment. It is
a well accepted and recommended form of treatment in England,
Italy, Ireland, the Netherlands, Russia, Israel, Japan, Canada,
India, Venezuela and many other countries in Europe, South
America and the Far East. A low powered laser procedure does not
cut or burn into the skin or affected areas-it stimulates the
cells and tissue and promotes healing by penetrating deep into
the tissues initializing the process of photo biostimulation.
The patient feels no discomfort related to the procedure. The
light energy from the low level laser is absorbed in cytochromes
and porphyrins within cell mitochondria and cell membranes. A
small amount of Singlet Oxygen is produced as a result of the
absorption. This is combined with a number of other factors to
produce the results demonstrated in many thousands of clinical
study cases. Each case is different and the program utilized
varies with the severity on the condition. In many instances, a
review of the literature indicates that low level laser therapy
may be a viable alternative to surgery. If you are a medical
professional who has interest in LLLT, please contact us for
information on how to become part of our team. |
